F.D.A. Panel Splits on Whether to Approve New Diabetes Drug

The advisory committee voted 8-8 on approving the drug, to be called Zynquista, which would be the first oral medication for people with Type 1 diabetes. KATIE THOMAS https://nyti.ms/2FGsGur http://bit.ly/2CpoHPE The New York Times Health Drugs (Pharmaceuticals), Diabetes January 17, 2019 at 12:00AM